Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu

Updated on: December 26,2023

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu

Updated on:December 26,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on: December 22,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on:December 22,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on: July 17,2024

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on:July 17,2024

Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

by Teddy RosenbluthCredit: Unsplash/CC0 Public DomainAfter six years of painful injections, Stephanie Walker has had enough.Every 28 days, she drives an hour to Duke's Cancer center to get 50 mL s

Updated on: December 26,2023

Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

by Teddy RosenbluthCredit: Unsplash/CC0 Public DomainAfter six years of painful injections, Stephanie Walker has had enough.Every 28 days, she drives an hour to Duke's Cancer center to get 50 mL s

Updated on:December 26,2023

Organ transplant does not worsen prostate cancer outcome

(HealthDay)—Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM), according to a study published onl

Updated on: December 22,2023

Organ transplant does not worsen prostate cancer outcome

(HealthDay)—Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM), according to a study published onl

Updated on:December 22,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on: December 27,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on:December 27,2023

Researchers uncover dangers of celebrating 'victory' over cancer

by Eric Lindberg,University of Southern CaliforniaResearchers find that bell-ringing rituals might reinforce negative memories of cancer treatment. Credit: Photo/F. Carter SmithIt's a staple

Updated on: June 11,2024

Researchers uncover dangers of celebrating 'victory' over cancer

by Eric Lindberg,University of Southern CaliforniaResearchers find that bell-ringing rituals might reinforce negative memories of cancer treatment. Credit: Photo/F. Carter SmithIt's a staple

Updated on:June 11,2024

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese

Updated on: January 07,2024

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese

Updated on:January 07,2024

Customizing T cell-based immunotherapies using new 'SNAPtag' technology

byUniversity of PittsburghUniversal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. Th

Updated on: January 04,2024

Customizing T cell-based immunotherapies using new 'SNAPtag' technology

byUniversity of PittsburghUniversal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. Th

Updated on:January 04,2024

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Updated on: December 02,2024

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Updated on:December 02,2024